News Focus
News Focus
Followers 188
Posts 11661
Boards Moderated 2
Alias Born 12/08/2016

Re: Neverhadawinner post# 172576

Monday, 01/27/2020 5:11:34 PM

Monday, January 27, 2020 5:11:34 PM

Post# of 205196
It appears that PAS/OAS are marketing the heck out of the Arrayit allergy fingerstick test coupled with Allerdent’s immunotherapy toothpaste by looking at the growing amount of clinics offering this program...PAS is for children & OAS is for adults.

https://www.globenewswire.com/news-release/2017/12/19/1266153/0/en/New-Test-and-Treatment-Allergy-Program-Enables-All-Physicians-To-Provide-Convenient-And-Effective-Allergy-Care.html

1)”Pediatric Allergy Solutions (“PAS”) and Allovate Therapeutics (“Allovate®”) announce that they have signed an exclusive agreement to combine PAS’s simple and minimally invasive fingerstick allergy test (the “Test”) and Allovate’s Allerdent®, a patented toothpaste-based system for the delivery of allergy immunotherapy (the “Treatment”) to enable primary care physicians to offer personalized allergy care.”

2) “The dried blood samples are sent to a PAS laboratory partner to be assessed for 145 different respiratory and food allergy sensitivities using a proprietary macroarray based technology.”

See sample report:

https://storage.googleapis.com/wzukusers/user-27922100/documents/5be9c697a0feacHGfCzT/01)%20PAS%20-%20Sales%20-%20Sample%20Report%20-%20110118-2.pdf

https://optimumallergysolutions.com/va

4) They are moving forward in the clinical trials for peanut immunotherapy. They will be amongst the first companies if successful.

https://www.marketwatch.com/press-release/cutting-edge-immunotherapy-for-peanut-allergy-presented-at-biotech-showcasetm-2020-2020-01-13

All my posts are in my opinion only.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y